Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 98-102, 2020.
Article
em En
| WPRIM
| ID: wpr-811441
Biblioteca responsável:
WPRO
ABSTRACT
Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and may require transjugular intrahepatic portosystemic shunt (TIPS) or liver transplant. Successful antiviral therapy reduces the incidence of some complications of cirrhosis secondary to HCV infection. We report a case of hepatic hydrothorax in a 55-year-old female patient with HCV cirrhosis, which exhibited a spontaneous decrease in pleural effusion after direct antiviral agent (DAA) therapy. In cases of HCV cirrhosis, DAAs are worth administering before treatment by TIPS or liver transplantation.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Antivirais
/
Derrame Pleural
/
Fibrose
/
Derivação Portossistêmica Cirúrgica
/
Incidência
/
Transplante de Fígado
/
Hepacivirus
/
Hepatite C Crônica
/
Diuréticos
/
Hepatite Crônica
Tipo de estudo:
Incidence_studies
/
Prognostic_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
The Korean Journal of Gastroenterology
Ano de publicação:
2020
Tipo de documento:
Article